Acceleron Pharma

+$0.78 (+0.64%) As of 7:24 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell XLRN and other ETFs, options, and stocks.

About XLRN

Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension.

CEO

Habib J. Dable

Employees

312

Headquarters

Cambridge, Massachusetts

Founded

2003

XLRN Key Statistics

Market Cap

7.71B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

303.98K

High Today

$123.81

Low Today

$120.76

Open Price

$122.70

Volume

80.91K

52 Week High

$146.15

52 Week Low

$85.58

Analyst Ratings

83%

of 12 ratings

Buy

83.3%

Hold

16.7%

Sell

XLRN Earnings

-$1.05

-$0.70

-$0.35

$0.00

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

— per share

Actual

Expected Aug 5, After Hours